Amneal Pharmaceuticals (AMRX)
(Real Time Quote from BATS)
$8.78 USD
-0.03 (-0.34%)
Updated Sep 20, 2024 11:14 AM ET
3-Hold of 5 3
A Value B Growth D Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | 0.13 |
EPS Last Quarter | 0.16 |
Last EPS Surprise | 14.29% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.59 |
Next Year | 0.64 |
EPS (TTM) | 0.63 |
P/E (F1) | 15.02 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 690.18M | 697.75M | 2.75B | 2.85B |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 699.70M | 711.72M | 2.77B | 2.95B |
Low Estimate | 671.99M | 689.24M | 2.72B | 2.76B |
Year ago Sales | 620.04M | 616.98M | 2.39B | 2.75B |
Year over Year Growth Est. | 11.31% | 13.09% | 14.84% | 3.51% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.13 | 0.16 | 0.59 | 0.64 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.15 | 0.18 | 0.59 | 0.73 |
Low Estimate | 0.12 | 0.14 | 0.58 | 0.49 |
Year ago EPS | 0.19 | 0.14 | 0.64 | 0.59 |
Year over Year Growth Est. | -31.58% | 14.29% | -7.81% | 9.04% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 2 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.13 | 0.16 | 0.59 | 0.64 |
7 Days Ago | 0.13 | 0.16 | 0.59 | 0.64 |
30 Days Ago | 0.13 | 0.16 | 0.59 | 0.64 |
60 Days Ago | 0.14 | 0.16 | 0.58 | 0.60 |
90 Days Ago | 0.14 | 0.16 | 0.58 | 0.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.13 | 0.16 | 0.59 | 0.64 |
Zacks Consensus Estimate | 0.13 | 0.16 | 0.59 | 0.64 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.16 | 0.14 | 0.14 | 0.19 | NA |
Estimate | 0.14 | 0.09 | 0.07 | 0.12 | NA |
Difference | 0.02 | 0.05 | 0.07 | 0.07 | 0.05 |
Surprise | 14.29% | 55.56% | 100.00% | 58.33% | 57.05% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more